Logo Logo
Hilfe
Hilfe
Switch Language to English

Goetz, Philipp; Azubuike-Osu, Sharon O.; Braumandl, Anna; Arnholdt, Christoph; Kuebler, Matthias; Richter, Lisa; Lasch, Manuel; Bobrowski, Lisa; Preissner, Klaus T. und Deindl, Elisabeth (2022): Cobra Venom Factor Boosts Arteriogenesis in Mice. In: International Journal of Molecular Sciences, Bd. 23, Nr. 15, 8454

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Arteriogenesis, the growth of natural bypass blood vessels, can compensate for the loss of arteries caused by vascular occlusive diseases. Accordingly, it is a major goal to identify the drugs promoting this innate immune system-driven process in patients aiming to save their tissues and life. Here, we studied the impact of the Cobra venom factor (CVF), which is a C3-like complement-activating protein that induces depletion of the complement in the circulation in a murine hind limb model of arteriogenesis. Arteriogenesis was induced in C57BL/6J mice by femoral artery ligation (FAL). The administration of a single dose of CVF (12.5 mu g) 24 h prior to FAL significantly enhanced the perfusion recovery 7 days after FAL, as shown by Laser Doppler imaging. Immunofluorescence analyses demonstrated an elevated number of proliferating (BrdU(+)) vascular cells, along with an increased luminal diameter of the grown collateral vessels. Flow cytometric analyses of the blood samples isolated 3 h after FAL revealed an elevated number of neutrophils and platelet-neutrophil aggregates. Giemsa stains displayed augmented mast cell recruitment and activation in the perivascular space of the growing collaterals 8 h after FAL. Seven days after FAL, we found more CD68(+)/MRC-1(+) M2-like polarized pro-arteriogenic macrophages around growing collaterals. These data indicate that a single dose of CVF boosts arteriogenesis by catalyzing the innate immune reactions, relevant for collateral vessel growth.

Dokument bearbeiten Dokument bearbeiten